0VY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NovaBridge Biosciences

Watchlist Manager

Watchlist

Price: 0.93 EUR -11.43% Market Closed

Market Cap: €75.2m

	NovaBridge Biosciences F:0VY	US
	GlobeStar Therapeutics Corp OTC:GSTC	US
O	Old National Bancorp F:ON1	US
M	Mon Courtier Energie SAS PAR:ALMCE	FR
G	Givaudan SA XMUN:GIN	CH
	Molinos Rio de la Plata SA OTC:MOPLF	AR
	Meko AB F:1OM	SE
P	Poly Property Group Co Ltd F:CMJ	HK
	Mizuno Corp F:MIZ	JP
F	Forcs Co Ltd KOSDAQ:189690	KR
	Davictus PLC LSE:DVT	MY
R	Rigolleau SA BCBA:RIGO	AR
	WisdomTree Inc F:1WT	US
	La Francaise de l Energie SA F:LFX	FR
	Shufersal Ltd OTC:SHUFF	IL
	Promotora de Informaciones SA MAD:PRS	ES
T	Tocvan Ventures Corp CNSX:TOC	CA

Profitability Summary

NovaBridge Biosciences's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

1,094%

Low Operating Margin

Negative 3Y Average Operating Margin

-2,284%

Low Net Margin

Negative 3Y Average Net Margin

-8,511%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

17,830%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

98% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.